VC
VTYX

Vivo Capital’s Ventyx Biosciences VTYX Stock Holding History

Vivo Capital’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-422,075
Closed -$14.7M – 53
2023
Q3 		$14.7M Hold
422,075
– – 1.61% 16
2023
Q2 		$13.8M Sell
422,075
-180,000
-30% -$6.2M 0.96% 16
2023
Q1 		$20.2M Sell
602,075
-701,219
-54% -$27.3M 1.4% 14
2022
Q4 		$42.7M Sell
1,303,294
-52,567
-4% -$1.56M 4.92% 7
2022
Q3 		$47.3M Sell
1,355,861
-565,865
-29% -$12.5M 5.23% 3
2022
Q2 		$23.5M Hold
1,921,726
– – 2.36% 10
2022
Q1 		$26.1M Buy
1,921,726
+130,451
+7% +$1.74M 1.8% 11
2021
Q4 		$35.6M Buy
+1,791,275
New +$33.9M 2.15% 13

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vivo Capital's VTYX Position: Q4 2023 in Review

Vivo Capital sold out of Ventyx Biosciences (VTYX) in Q4 2023, closing a stake of 422,075 shares — an estimated $14.7M sold.

Vivo Capital first reported a position in VTYX in Q4 2021 and held it in 8 quarters. The position peaked at $47.3M in Q3 2022. 121 funds tracked by Wall St. Rank hold VTYX as of Q4 2023.

  • Vivo Capital reported no remaining Ventyx Biosciences position as of Q4 2023 after selling out during the quarter.
  • Vivo Capital sold 422,075 Ventyx Biosciences shares in Q4 2023, an estimated $14.7M.
  • Vivo Capital first reported a position in Ventyx Biosciences in Q4 2021 and held it in 8 quarters.
  • Vivo Capital's Ventyx Biosciences position peaked at $47.3M in Q3 2022.
  • 121 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2023.

Based on Vivo Capital's 13F filing for Q4 2023, filed 7 Feb 2024.